Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?
| datacite.relatedItem.firstPage | 31 | |
| datacite.relatedItem.issue | 3 | |
| datacite.relatedItem.relatedIdentifierType | ISSN | |
| datacite.relatedItem.relatedItemIdentifier | 2304-6740 | |
| datacite.relatedItem.relationType | IsPublishedIn | |
| datacite.relatedItem.title | Inorganics | |
| datacite.relatedItem.volume | 7 | |
| dc.contributor.author | James P. C. Coverdale | |
| dc.contributor.author | Thaisa Laroiya-McCarron | |
| dc.contributor.author | Isolda Romero-Canelón | |
| dc.date.accessioned | 2024-08-15T14:03:41Z | |
| dc.date.available | 2024-08-15T14:03:41Z | |
| dc.date.issued | 2019 | |
| dc.identifier.doi | https://doi.org/10.3390/inorganics7030031 | |
| dc.identifier.other | jz000074-0075 | |
| dc.identifier.uri | https://tustorage.ulb.tu-darmstadt.de/handle/tustorage/7098 | |
| dc.publisher | MDPI AG | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.ddc | 540 | |
| dc.title | Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates? | |
| dc.type | Article | |
| dcat.distribution.pdf | https://tustorage.ulb.tu-darmstadt.de/handle/tustorage/7099 | |
| dcat.distribution.supplierxml | https://tustorage.ulb.tu-darmstadt.de/handle/tustorage/7100 | |
| dspace.entity.type | Dataset | |
| relation.isDistributionOfDataset | 66901a03-c25d-48f4-bb37-ae6b2d7433b1 | |
| relation.isDistributionOfDataset | 199677a4-2127-4b6e-b154-abd373170302 | |
| relation.isDistributionOfDataset | a85211c9-1d98-4694-a5b7-0a5d27ef246e | |
| relation.isDistributionOfDataset.latestForDiscovery | 66901a03-c25d-48f4-bb37-ae6b2d7433b1 | |
| wdm.archivematicaaipuuid.original | 2dad3707-17ba-4f63-8780-3ce5ea185681 |